Therefore, this report was aimed to better clarify the mutual effects of these pathogenic abnormalities in overweight or obese PCOS patients subdivided into insulin-resistant (IR) and insulin-sensitive (IS) groups. Here, INS is linked to polycystic ovary syndrome.